EWA
IRWD icon

EverSource Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

EverSource Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.1K Sell
11,905
-8,431
-41% -$32.5K ﹤0.01% 1780
2026
Q1 		$71.4K Buy
20,336
+6,656
+49% +$27.3K ﹤0.01% 1643
2025
Q4 		$46.1K Sell
13,680
-891
-6% -$2.31K ﹤0.01% 1794
2025
Q3 		$19.1K Buy
14,571
+2,550
+21% +$2.64K ﹤0.01% 2393
2025
Q2 		$8.62K Buy
12,021
+11,388
+1,799% +$8.94K ﹤0.01% 2895
2025
Q1 		$930 Buy
633
+586
+1,247% +$1.4K ﹤0.01% 3255
2024
Q4 		$208 Buy
+47
New +$191 ﹤0.01% 3427

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

EverSource Wealth Advisors's IRWD Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 41% in Q2 2026, selling an estimated $32.5K and leaving 11,905 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

EverSource Wealth Advisors first reported a position in IRWD in Q4 2024 and has held it in 7 quarters since. The position peaked at $71.4K in Q1 2026. 53 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • EverSource Wealth Advisors held 11,905 shares of Ironwood Pharmaceuticals worth $50.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 8,431 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $32.5K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1780 holding.
  • EverSource Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Ironwood Pharmaceuticals position peaked at $71.4K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.